Hjem › Burkitts lymfom › Massachusetts › Worcester
Burkitts lymfom kliniske forsøg i Worcester, MA
3 studier for Burkitts lymfom søger deltagere på steder i og omkring Worcester (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- UMass Memorial Medical Center - University Campus, Worcester
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- UMass Memorial Medical Center - University Campus, Worcester
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- UMass Memorial Medical Center - University Campus, Worcester
Burkitts lymfom forsøg i andre byer
- Houston, TX21 studier
- Milwaukee, WI16 studier
- Philadelphia, PA16 studier
- New York City, NY14 studier
- Chicago, IL14 studier
- Cincinnati, OH12 studier
- Atlanta, GA12 studier
- Seattle, WA11 studier
- Boston, MA10 studier
- Durham, NC10 studier
- Aurora, CO10 studier
- Los Angeles, CA10 studier
Andre studier i Worcester
- Ikke-småcellet lungecancer14 studier
- Lungecancer11 studier
- Kræft (alle typer)7 studier
- Brystkræft6 studier
- Skizofreni5 studier
- Metastatisk cancer5 studier
- Prostatakræft5 studier
- Ægstockræft5 studier
- Alvorlig depressiv lidelse5 studier
- Depression5 studier
- Akut myeloid leukæmi5 studier
- Urotelial (overgangscelle) carcinom4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.